{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:58:59Z","timestamp":1790996339852,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["1023031500037-7-1.6.8"],"award-info":[{"award-number":["1023031500037-7-1.6.8"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["1.6.3"],"award-info":[{"award-number":["1.6.3"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuroscience.2025.10.025","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T07:13:56Z","timestamp":1760512436000},"page":"142-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Decreased DNA methyltransferase 1 level in blood cells in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"588","author":[{"given":"A.O.","family":"Lavrinova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1244-7929","authenticated-orcid":false,"given":"E.M.","family":"Litusova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Gagarina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6827-9584","authenticated-orcid":false,"given":"A.A.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8083-3018","authenticated-orcid":false,"given":"N.V.","family":"Melnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"Demidova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8495-5581","authenticated-orcid":false,"given":"A.S.","family":"Zhuravlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.","family":"Kulabukhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.V.","family":"Miliukhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Timofeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.A.","family":"Berkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.N.","family":"Pchelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3249-7889","authenticated-orcid":false,"given":"A.K.","family":"Emelyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.10.025_b0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2013.11.033","article-title":"Hypomethylation of SNCA in blood of patients with sporadic Parkinson\u2019s disease","volume":"337","author":"Ai","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.025_b0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.025_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1010991020245","article-title":"Is there a rationale for neuroprotection against dopamine toxicity in Parkinson\u2019s disease?","volume":"21","author":"Barzilai","year":"2001","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.025_b0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00401-020-02202-1","article-title":"Genetics of synucleins in neurodegenerative diseases","volume":"141","author":"Br\u00e1s","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.10.025_b0025","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.neurobiolaging.2008.06.010","article-title":"Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease","volume":"31","author":"Brighina","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.025_b0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/157015911795596612","article-title":"The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders","volume":"9","author":"Buttarelli","year":"2011","journal-title":"Curr. Neuropharmacol."},{"issue":"9440","key":"10.1016\/j.neuroscience.2025.10.025_b0035","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2025.10.025_b0040","first-page":"179","article-title":"Establishment and maintenance of DNA methylation patterns in mammals","volume":"301","author":"Chen","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.025_b0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/acel.12485","article-title":"Age-dependent expression of DNMT1 and DNMT3B in PBMCs from a large European population enrolled in the MARK-AGE study","volume":"15","author":"Ciccarone","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuroscience.2025.10.025_b0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1196\/annals.1299.124","article-title":"Dopaminergic modulation of apoptosis in human peripheral blood mononuclear cells: possible relevance for Parkinson\u2019s disease","volume":"1010","author":"Colombo","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.10.025_b0055","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/gb-2012-13-6-r43","article-title":"Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood","volume":"13","author":"Davies","year":"2012","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.025_b0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/mds.30094","article-title":"\u03b1\u2010synuclein gene hypomethylation in LRRK2 Parkinson\u2019s disease patients","volume":"40","author":"De Mena","year":"2025","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.10.025_b0065","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1074\/jbc.C110.212589","article-title":"Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases","volume":"286","author":"Desplats","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2025.10.025_b0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2014.11.002","article-title":"Global changes in DNA methylation in Alzheimer\u2019s disease peripheral blood mononuclear cells","volume":"45","author":"Di Francesco","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.10.025_b0075","first-page":"2302","article-title":"CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression","volume":"59","author":"Eads","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuroscience.2025.10.025_b0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jns.2018.10.002","article-title":"SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson\u2019s disease","volume":"395","author":"Emelyanov","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.10.025_b0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1134\/S1990519X18050024","article-title":"The effect of dopamine on gene expression of alpha-synuclein and transcription factors GATA-1, GATA-2, and ZSCAN21 in Parkinson\u2019s disease","volume":"12","author":"Emelyanov","year":"2018","journal-title":"Cell Tissue Biol."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.10.025_b0090","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/mds.28688","article-title":"Increased \u03b1-synuclein level in CD45+ blood cells in asymptomatic carriers of GBA mutations","volume":"36","author":"Emelyanov","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.10.025_b0095","article-title":"Four copies of SNCA responsible for autosomal dominant Parkinson\u2019s disease in two Italian siblings","volume":"2015","author":"Ferese","year":"2015","journal-title":"Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.10.025_b0100","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1096\/fj.07-9348com","article-title":"Genetic variability in the SNCA gene influences \u03b1-synuclein levels in the blood and brain","volume":"22","author":"Fuchs","year":"2008","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.025_b0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jnr.10663","article-title":"Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells","volume":"73","author":"G\u00f3mez-Santos","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2025.10.025_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107247","article-title":"Advancing personalized medicine in neurodegenerative diseases: the role of epigenetics and pharmacoepigenomics in pharmacotherapy","volume":"205","author":"Gri\u00f1\u00e1n-Ferr\u00e9","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.025_b0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/15592294.2019.1588682","article-title":"DNA methylation changes associated with Parkinson\u2019s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood","volume":"14","author":"Henderson-Smith","year":"2019","journal-title":"Epigenetics"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.10.025_b0120","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrg3270","article-title":"DNA methylation profiling in the clinic: applications and challenges","volume":"13","author":"Heyn","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"Pt 3","key":"10.1016\/j.neuroscience.2025.10.025_b0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.10.025_b0130","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.18632\/aging.100859","article-title":"Increased epigenetic age and granulocyte counts in the blood of Parkinson\u2019s disease patients","volume":"7","author":"Horvath","year":"2015","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.025_b0135","first-page":"38","article-title":"Genome-wide DNA hypermethylation and homocysteine increase a risk for myopia","volume":"12","author":"Hsi","year":"2019","journal-title":"Int. J. Ophthalmol."},{"issue":"Suppl","key":"10.1016\/j.neuroscience.2025.10.025_b0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch","year":"2003","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.10.025_b0145","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/biom13081263","article-title":"Alpha-synuclein in peripheral tissues as a possible marker for neurological diseases and other medical conditions","volume":"13","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.025_b0150","first-page":"1204","article-title":"Disruption of dopamine homeostasis associated with alteration of proteins in synaptic vesicles: a putative central mechanism of Parkinson\u2019s disease pathogenesis","volume":"15","author":"Jin","year":"2023","journal-title":"Aging Dis."},{"issue":"18","key":"10.1016\/j.neuroscience.2025.10.025_b0155","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.025_b0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchemneu.2018.12.005","article-title":"5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson\u2019s disease","volume":"96","author":"Kaut","year":"2019","journal-title":"J. Chem. Neuroanat."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.025_b0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jgg.2018.02.003","article-title":"Developing DNA methylation-based diagnostic biomarkers","volume":"45","author":"Kim","year":"2018","journal-title":"J. Genet. Genomics"},{"issue":"7472","key":"10.1016\/j.neuroscience.2025.10.025_b0170","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature12750","article-title":"TET enzymes, TDG and the dynamics of DNA demethylation","volume":"502","author":"Kohli","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.025_b0175","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.exger.2009.12.008","article-title":"Age-dependent decreases in DNA methyltransferase levels and low transmethylation micronutrient levels synergize to promote overexpression of genes implicated in autoimmunity and acute coronary syndromes","volume":"45","author":"Li","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.025_b0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.neuroscience.2025.10.025_b0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fnagi.2013.00085","article-title":"DNA methylation, a hand behind neurodegenerative diseases","volume":"5","author":"Lu","year":"2013","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.10.025_b0190","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.3390\/ijms21062220","article-title":"DNA methylation in neurodegenerative and cerebrovascular disorders","volume":"21","author":"Mart\u00ednez-Iglesias","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.025_b0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ijms23010013","article-title":"Epigenetic biomarkers as diagnostic tools for neurodegenerative disorders","volume":"23","author":"Mart\u00ednez-Iglesias","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.025_b0200","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/genes14020365","article-title":"DNA methylation as a biomarker for monitoring disease outcome in patients with hypovitaminosis and neurological disorders","volume":"14","author":"Mart\u00ednez-Iglesias","year":"2023","journal-title":"Genes (Basel)"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.10.025_b0205","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4161\/epi.25865","article-title":"Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes","volume":"8","author":"Masliah","year":"2013","journal-title":"Epigenetics"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.10.025_b0210","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/archneurol.2010.279","article-title":"SNCA variant associated with parkinson disease and plasma \u03b1-synuclein level","volume":"67","author":"Mata","year":"2010","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.10.025_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015522","article-title":"CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson\u2019s disease","volume":"5","author":"Matsumoto","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2025.10.025_b0220","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroscience.2021.05.027","article-title":"Alpha-synuclein-induced DNA methylation and gene expression in Microglia","volume":"468","author":"McGregor","year":"2021","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.025_b0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.10.025_b0230","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00702-023-02666-x","article-title":"The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson\u2019s disease","volume":"131","author":"M\u00fcller","year":"2024","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.025_b0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0304-3940(01)01972-3","article-title":"Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson\u2019s disease","volume":"308","author":"M\u00fcller","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.10.025_b0240","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1373\/clinchem.2009.125021","article-title":"Methylation status and neurodegenerative markers in Parkinson disease","volume":"55","author":"Obeid","year":"2009","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.025_b0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.10.025_b0250","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.3390\/ijms24119547","article-title":"Parkinson\u2019s disease: from genetics and epigenetics to treatment, a miRNA-based strategy","volume":"24","author":"Paccosi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.10.025_b0255","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbagen.2016.06.018","article-title":"L-DOPA-induced hyperhomocysteinemia in Parkinson\u2019s disease: elephant in the room","volume":"1860","author":"Paul","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.10.025_b0260","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10517-011-1221-3","article-title":"Reduced content of \u03b1-synuclein in peripheral blood leukocytes of patients with LRRK2-associated Parkinson\u2019s disease","volume":"150","author":"Pchelina","year":"2011","journal-title":"Bull. Exp. Biol. Med."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.10.025_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02590","article-title":"Alpha synuclein in hematopoiesis and immunity","volume":"5","author":"Pei","year":"2019","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.025_b0270","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/mds.26073","article-title":"Parkinson\u2019s disease correlates with promoter methylation in the \u03b1\u2010synuclein gene","volume":"30","author":"Pihlstr\u00f8m","year":"2015","journal-title":"Mov. Disord."},{"issue":"5321","key":"10.1016\/j.neuroscience.2025.10.025_b0275","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.10.025_b0280","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.10.025_b0285","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.neuroscience.2025.10.025_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.971298","article-title":"DNA methylation as a mediator of genetic and environmental influences on Parkinson\u2019s disease susceptibility: impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenome","volume":"13","author":"Schaffner","year":"2022","journal-title":"Front. Genet."},{"issue":"13","key":"10.1016\/j.neuroscience.2025.10.025_b0295","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/mds.26319","article-title":"L-dopa increases \u03b1-synuclein DNA methylation in Parkinson\u2019s disease patients in vivo and in vitro","volume":"30","author":"Schmitt","year":"2015","journal-title":"Mov. Disord."},{"issue":"5646","key":"10.1016\/j.neuroscience.2025.10.025_b0300","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-synuclein locus triplication causes Parkinson\u2019s disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"6645","key":"10.1016\/j.neuroscience.2025.10.025_b0305","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2025.10.025_b0310","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41531-017-0007-3","article-title":"Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson\u2019s disease","volume":"3","author":"St\u00f6ger","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.025_b0315","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.parkreldis.2013.12.002","article-title":"Methylation of \u03b1-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson\u2019s disease patients","volume":"20","author":"Tan","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.10.025_b0320","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.3390\/ijms19103199","article-title":"Pharmacoepigenomic interventions as novel potential treatments for Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"19","author":"Teijido","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.025_b0325","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/metabo14010030","article-title":"Altered sphingolipid hydrolase activities and alpha-synuclein level in late-onset schizophrenia","volume":"14","author":"Usenko","year":"2023","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.025_b0330","doi-asserted-by":"crossref","first-page":"43","DOI":"10.25692\/ACEN.2020.2.6","article-title":"Gene expression of lysosomal membrane proteins in parkinson disease, associated with mutations in the glucocerebrosidase gene (GBA)","volume":"14","author":"Usenko","year":"2020","journal-title":"Ann. Clin. Exp. Neurol."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.10.025_b0335","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molmed.2006.09.007","article-title":"Understanding the molecular causes of Parkinson\u2019s disease","volume":"12","author":"Wood-Kaczmar","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.025_b0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4161\/epi.6.1.13391","article-title":"Global methylation profiles in DNA from different blood cell types","volume":"6","author":"Wu","year":"2011","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.025_b0345","first-page":"152","article-title":"Dynamic regulation of DNA methylation and brain functions","volume":"12","author":"Xie","year":"2023","journal-title":"Biology (Basel)"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.025_b0350","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JPD-223517","article-title":"DNA methylation signature of aging: potential impact on the pathogenesis of Parkinson\u2019s disease","volume":"13","author":"Yazar","year":"2023","journal-title":"J. Parkinsons Dis."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.10.025_b0355","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1007\/s12035-021-02298-w","article-title":"DNA methyltransferase 1 is dysregulated in Parkinson\u2019s disease via mediation of miR-17","volume":"58","author":"Zhang","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.10.025_b0360","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0047-6374(02)00014-3","article-title":"Age-dependent DNA methylation changes in the ITGAL (CD11a) promoter","volume":"123","author":"Zhang","year":"2002","journal-title":"Mech. Ageing Dev."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.025_b0365","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3233\/JPD-201912","article-title":"SNCA hypomethylation in rapid eye movement sleep behavior disorder is a potential biomarker for Parkinson\u2019s disease","volume":"10","author":"Zhao","year":"2020","journal-title":"J. Parkinsons Dis."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225010176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225010176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T04:58:42Z","timestamp":1763614722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225010176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":73,"alternative-id":["S0306452225010176"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.10.025","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased DNA methyltransferase 1 level in blood cells in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}